iSTAR Medical initiates international STAR-VI trial for the

MINIject® is the only commercially available MIGS implant targeting the supraciliary space Clinical data show positive, consistent results up to two-year follow-up in patients across Europe, Asia

Related Keywords

United States , Wavre , Waals Gewest , Belgium , America , Dennis Riedl , Mahmoud Radwan , Chris Welsh , Iqbal Ikek Ahmed , Amber Fennell , Michel Vanbrabant , Paul Van Hagen , University Of Utah United States , Colchester Eye Centre , Department Of Ophthalmology , Prism Eye Institute , Consilium Strategic Communications , Iqbal Ike , Visual Sciences , Chief Innovation Officer , Consultant Ophthalmologist , United Kingdom , Financial Officer , Distar , Medical , Nitiates , Nternational , Star , Trial , Iniject , Conjunction , Cataract , Surgery ,